| Univariate analysis | |||||
---|---|---|---|---|---|---|
 | Disease-specific survival | Overall survival | ||||
Variable | HR (95% CI) | p-value | C-index | HR (95% CI) | p-value | C-index |
Age | 1.02 (0.96-1.08) | 0.58 | 0.56 | 1.05 (1.01-1.09) | 0.02 | 0.67 |
Tumor site | - | 0.24 | 0.67 | 0.92 (0.31-2.68) | 0.87 | 0.53 |
Tumor size | 31.59 (1.57-633.64) | 0 | 0.66 | 15.93 (1.41-179.93) | 0.02 | 0.58 |
Node status | - | 0 | 0.84 | 2.96 (1.19-7.39) | 0.02 | 0.64 |
Differentiation | - | 0.11 | 0.73 | 0.95 (0.17-5.18) | 0.11 | 0.63 |
Tumor inflammatory infiltration | 3.91 (0.46-33.48) | 0.20 | 0.67 | 0.91 (0.31-2.72) | 0.99 | 0.51 |
p16 | 0.62 (0.074-5.16) | 0.65 | 0.53 | 0.69 (0.20-2.36) | 0.55 | 0.53 |
AZGP1 cytoplasmic | 0.95 (0.18-4.87) | 0.95 | 0.51 | 0.88 (0.33-2.32) | 0.80 | 0.52 |
AZGP1 nuclear | 4.57 (0.55-38.01) | 0.12 | 0.65 | 0.86 (0.35-2.12) | 0.75 | 0.52 |
BTG2 | 1.25 (0.28-5.58) | 0.77 | 0.53 | 0.79 (0.30-2.07) | 0.63 | 0.53 |
CBX2 | - | 0.15 | 0.61 | 1.12 (0.37-3.37) | 0.84 | 0.51 |
CNTNAP2 | 5.70 (1.27-25.57) | 0.01 | 0.66 | 1.34 (0.39-4.62) | 0.65 | 0.52 |
NME5 | 0.37 (0.045-3.11) | 0.34 | 0.58 | 0.58 (0.19-1.75) | 0.33 | 0.56 |
S100A8 | 0.35 (0.043-2.95) | 0.32 | 0.59 | 0.10 (0.014-0.76) | 0.01 | 0.65 |
SCUBE2 | - | 0.090 | 0.65 | 1.25 (0.47-3.33) | 0.65 | 0.53 |
SERPINA11 | 2.23 (0.50-9.99) | 0.28 | 0.60 | 0.98 (0.39-2.50) | 0.97 | 0.50 |
STC2 | 0.17 (0.023-1.71) | 0.10 | 0.68 | 0.68 (0.27-1.69) | 0.40 | 0.55 |
STK32B | 0.31 (0.037-2.54) | 0.25 | 0.61 | 0.47 (0.16-1.41) | 0.17 | 0.58 |
SUSD3 | 1.60 (0.31-8.26) | 0.57 | 0.55 | 0.54 (0.22-1.34) | 0.18 | 0.58 |
UBE2C | 2.56 (0.49-13.28) | 0.25 | 0.57 | 2.49 (0.88-7.01) | 0.074 | 0.57 |
WHSC1L1 | 0.86 (0.10-7.16) | 0.89 | 0.51 | 1.18 (0.27-5.10) | 0.83 | 0.51 |
 | Multivariate analysis | |||||
 | Disease- specific survival | Overall survival | ||||
 | HR (95% CI) | p- value | C-index | HR (95% CI) | p- value | C- index |
CNTNAP2 †| 3.56 (0.78-16.17) | 0.10 | 0.95 | - | - | - |
S100A8 ‡ | - | - | - | 0.11 (0.013-0.92) | 0.01 | 0.83 |